Results for tag: "Gastrointestinal Bleeding"

Gastrointestinal Bleeding (GIB) is a medical condition in which blood is lost from the gastrointestinal tract. It can be caused by a variety of conditions, including ulcers, tumors, and trauma. GIB is a common complication of surgical procedures, such as abdominal surgery, and can lead to serious health complications. Treatment of GIB typically involves controlling the bleeding, restoring blood volume, and preventing further bleeding. Surgical procedures are often used to treat GIB, including endoscopic procedures, such as endoscopic hemostasis, and open surgical procedures, such as laparotomy. Endoscopic hemostasis is a minimally invasive procedure that uses a variety of techniques to stop the bleeding, such as suturing, cautery, and injection of clotting agents. Laparotomy is a more invasive procedure that involves making an incision in the abdomen to access the bleeding site. The GIB market is composed of a variety of companies that provide products and services related to the diagnosis and treatment of GIB. These include medical device companies that manufacture endoscopes and other instruments used in endoscopic procedures, pharmaceutical companies that produce clotting agents, and healthcare providers that offer surgical and endoscopic treatments. Examples of companies in the GIB market include Olympus Corporation, Boston Scientific Corporation, and Johnson & Johnson. Show Less Read more